We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

113 hedge funds and large institutions have $379M invested in Arcturus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 36 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more call options, than puts

Call options by funds: $6.67M | Put options by funds: $2.99M

16% more capital invested

Capital invested by funds: $328M → $379M (+$51.2M)

2.06% more ownership

Funds ownership: 83.4% → 85.46% (+2.1%)

6% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 36

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

3% less funds holding

Funds holding: 116 → 113 (-3)

Holders
113
Holders Change
-3
Holders Change %
-2.59%
% of All Funds
1.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
38
Reduced
36
Closed
20
Calls
$6.67M
Puts
$2.99M
Net Calls
+$3.68M
Net Calls Change
+$1.69M

Top Buyers

1
Federated Hermes
Federated Hermes
Pennsylvania
+$11.7M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$11.6M
3
Bank of America
Bank of America
North Carolina
+$10.1M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.79M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.98M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$9.64M
2
State Street
State Street
Massachusetts
-$8.24M
3
AIM
ARK Investment Management
Florida
-$2.95M
4
WP
Woodline Partners
California
-$2.18M
5
IHAM
Integral Health Asset Management
New York
-$1.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$71.9M +$11.7M +672,057 +19%
State Street
2
State Street
Massachusetts
$38.3M -$8.24M -472,616 -17%
AIM
3
ARK Investment Management
Florida
$34.1M -$2.95M -169,274 -8%
BlackRock
4
BlackRock
New York
$32M -$1.32M -75,704 -4%
Vanguard Group
5
Vanguard Group
Pennsylvania
$24.6M +$1.98M +113,607 +8%
Sumitomo Mitsui Trust Group
6
Sumitomo Mitsui Trust Group
Japan
$24.6M -$181K -10,355 -0.7%
NAMA
7
Nikko Asset Management Americas
New York
$24.6M -$181K -10,355 -0.7%
Balyasny Asset Management
8
Balyasny Asset Management
Illinois
$17M +$11.6M +664,852 +196%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$15.4M -$769K -44,082 -5%
WP
10
Woodline Partners
California
$12.8M -$2.18M -125,193 -14%
Bank of America
11
Bank of America
North Carolina
$11.6M +$10.1M +577,968 +535%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$7.63M +$578K +33,148 +8%
JP Morgan Chase
13
JP Morgan Chase
New York
$5.82M -$51.9K -2,974 -0.9%
Goldman Sachs
14
Goldman Sachs
New York
$5.23M -$336K -19,287 -6%
Citadel Advisors
15
Citadel Advisors
Florida
$5.14M +$1.97M +112,903 +59%
Northern Trust
16
Northern Trust
Illinois
$3.62M +$102K +5,863 +3%
Rafferty Asset Management
17
Rafferty Asset Management
New York
$3.55M -$902K -51,726 -20%
Charles Schwab
18
Charles Schwab
California
$3.03M +$135K +7,727 +5%
Morgan Stanley
19
Morgan Stanley
New York
$2.05M +$628K +36,042 +43%
Wells Fargo
20
Wells Fargo
California
$1.98M -$1.18M -67,666 -37%
Barclays
21
Barclays
United Kingdom
$1.84M -$214K -12,247 -10%
Citigroup
22
Citigroup
New York
$1.57M -$1.4M -80,512 -47%
Jane Street
23
Jane Street
New York
$1.45M +$947K +54,290 +175%
UBS Group
24
UBS Group
Switzerland
$1.44M +$1.42M +81,642 +2,346%
RA
25
Royce & Associates
New York
$1.35M – – –
1
2 3 4 5

ARCT Hedge Fund Activity: Q4 2022 in Review

113 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q4 2022, worth a combined $379M — up 16% from $328M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ARCT and 19 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 38 added.

The largest buyer was Federated Hermes, adding an estimated $11.7M. The largest seller was Point72 Asset Management, cutting an estimated $9.64M.

  • 113 institutional investors held Arcturus Therapeutics (ARCT) as of Q4 2022, down from 116 in Q3 2022.
  • Funds reported $379M of Arcturus Therapeutics stock for Q4 2022, up 16% quarter-over-quarter.
  • 19 funds opened new Arcturus Therapeutics positions in Q4 2022 and 20 closed out, a net change of -1 holder.
  • The largest Arcturus Therapeutics buyer in Q4 2022 was Federated Hermes, an estimated $11.7M added.
  • The largest Arcturus Therapeutics seller in Q4 2022 was Point72 Asset Management, an estimated $9.64M sold.

Based on aggregated 13F filings for Q4 2022.